Agenus logo

Agenus Share Price (NASDAQ: AGEN)

$4.55

0.02

(0.44%)

Live

Last updated on

Check the interactive Agenus Stock chart to analyse performance

Agenus stock performance

as on August 20, 2025 at 12:35 AM IST

  • Today's Low:$4.47
    Today's High:$4.55

    Day's Volatility :1.76%

  • 52 Weeks Low:$1.38
    52 Weeks High:$7.34

    52 Weeks Volatility :81.2%

Agenus Stock Returns

PeriodAgenus IncSector (Health Care)Index (Russel 2000)
3 Months
18.36%
1.1%
0.0%
6 Months
29.12%
-7.2%
0.0%
1 Year
-10.71%
-11.6%
0.0%
3 Years
-91.77%
2.2%
-9.6%

Agenus Inc Key Stats

Check Agenus key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.53
Open
$4.65
Today's High
$4.56
Today's Low
$4.47
Market Capitalization
$147.5M
Today's Volume
$247.8K
52 Week High
$7.34
52 Week Low
$1.38
Revenue TTM
$101.7M
EBITDA
$-78.5M
Earnings Per Share (EPS)
$-7.06
Profit Margin
-162.69%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1278.83%

Stock Returns calculator for Agenus Stock including INR - Dollar returns

The Agenus stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Agenus investment value today

Current value as on today

₹93,015

Returns

₹6,985

(-6.98%)

Returns from Agenus Stock

₹10,609 (-10.61%)

Dollar Returns*

₹3,624 (+3.62%)

Indian investors sentiment towards Agenus Stock

-19.47%

Period: Jul 19, 2025 to Aug 18, 2025. Change in 30 Days versus previous period

Investment in Agenus Shares from India has dropped by -19.47% over the past 30 days, indicating reduced transactional activity.

-66%

Period: Jul 19, 2025 to Aug 18, 2025. Change in 30 Days versus previous period

Search interest for Agenus Stock from India on INDmoney has decreased by -66% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Agenus Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    8.44%

  • BlackRock Inc

    5.84%

  • Geode Capital Management, LLC

    1.81%

  • Siren, L.L.C.

    1.67%

  • State Street Corp

    1.60%

  • AQR Capital Management LLC

    1.47%

Analyst Recommendation on Agenus Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Agenus(by analysts ranked 0 to 5 stars)

Agenus Share Price Target

What analysts predicted

Upside of 171.06%

Target:

$12.33

Current:

$4.55

Agenus share price target is $12.33, a slight Upside of 171.06% compared to current price of $4.55 as per analysts' prediction.

Agenus Stock Insights

  • Price Movement

    In the last 1 month, AGEN stock has moved down by -26.1%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 24.06M → 25.69M (in $), with an average increase of 6.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -25.32M → -27.95M (in $), with an average decrease of 10.4% per quarter
  • AGEN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.4% return, outperforming this stock by 77.1%
  • AGEN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 203.4%
  • Price to Sales

    ForAGEN every $1 of sales, investors are willing to pay $1.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $24.0 for every $1 of sales.

Agenus Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$103.5M
↓ 33.81%
Net Income
$-227.2M
↓ 7.55%
Net Profit Margin
-219.61%
↓ 62.39%

Agenus Technicals Summary

Sell

Neutral

Buy

Agenus is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Agenus Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Agenus Inc logo
-25.37%
29.12%
-10.71%
-91.77%
-94.87%
Regeneron Pharmaceuticals, Inc. logo
5.3%
-15.53%
-52.01%
-6.15%
-6.88%
Beone Medicines Ltd logo
9.32%
34.03%
65.78%
84.48%
35.61%
Vertex Pharmaceuticals Incorporated logo
-14.97%
-15.63%
-20.12%
32.68%
43.64%
Alnylam Pharmaceuticals, Inc. logo
42.53%
82.74%
66.44%
109.65%
235.02%

About Agenus Inc

Agenus Inc., a clinical-stage biotechnology company, discovers and develops therapies to activate the body's immune system against cancer and infections in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, a programmed death receptor-1 (PD-1) blocking antibody; AGEN1181, a human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody that is in Phase 2 trials in metastatic colorectal cancer (mCRC), pancreatic cancer, and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in clinical development; and BMS-986442, a TIGIT bispecific antibodies. In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monoclonal antibodies; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; UGN-301, a zalifrelimab intravesical solution for the treatment of cancers of the urinary tract t; and AGEN1884. The company operates under the Agenus, MiNK, Prophage, Retrocyte Display, and STIMULON trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., UroGen Pharma Ltd., Gilead Sciences, Inc., Incyte Corporation, and Merck Sharp & Dohme. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.
Organization
Agenus
Employees
316
CEO
Dr. Garo H. Armen Ph.D.
Industry
Health Technology

Key Management of Agenus Inc

NameTitle
Dr. Garo H. Armen Ph.D.
Founder, Executive Chairman & CEO
Ms. Christine M. Klaskin
VP of Finance, Principal Financial Officer & Principal Accounting Officer
Dr. Steven J. O'Day M.D., Ph.D.
Chief Medical Officer
Dr. Jennifer S. Buell Ph.D.
Director and President & CEO of MiNK Therapeutics
Craig Winter
Chief Information Officer
Mr. Zack Armen
Head of Investor Relations & Corporate Development
Ms. Stefanie Perna-Nacar
Chief Communications & Government Relations Officer
Ms. Tracy Mazza Clemente
Chief People Officer
Mr. Alfred Dadson
Chief Manufacturing Officer
Mr. Eric Humes
Chief Quality Officer

Important FAQs about investing in AGEN Stock from India :

What is Agenus share price today?

Agenus share price today is $4.55 as on . Agenus share today touched a day high of $4.55 and a low of $4.47.

What is the 52 week high and 52 week low for Agenus share?

Agenus share touched a 52 week high of $7.34 and a 52 week low of $1.38. Agenus stock price today i.e. is trending at $4.55, lower by 38.01% versus the 52 week high.

How to invest in Agenus Stock (AGEN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Agenus on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Agenus Shares that will get you 0.3297 shares as per Agenus share price of $4.55 per share as on August 20, 2025 at 12:35 AM IST.

What is the minimum amount required to buy Agenus Stock (AGEN) from India?

Indian investors can start investing in Agenus (AGEN) shares with as little as ₹86.938 or $1 (as of August 19, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹869.38 in Agenus stock (as per the Rupee-Dollar exchange rate as on August 19, 2025). Based on Agenus share’s latest price of $4.55 as on August 20, 2025 at 12:35 AM IST, you will get 2.1978 shares of Agenus. Learn more about fractional shares .

What are the returns that Agenus has given to Indian investors in the last 5 years?

Agenus stock has given -94.87% share price returns and 16.15% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?